Working to Reduce Conflict of Interest at the FDA

Link to NPA National Grand Rounds
Online Webcast Archive

May 29, 2014

Working to Reduce Conflict of Interest at the FDA

Featured Speaker:

  • John H. Powers, MD FACP FIDSA
    Associate Clinical Professor of Medicine
    George Washington University School of Medicine
    University of Maryland School of Medicine

Call Recording (forthcoming)
Link to Call Notes (forthcoming)


April 30, 2014

Creating Public Transparency of Industry-Physician Financial Relationships: An update from the Center for Medicare and Medicaid Services (CMS) on Open Payments

Featured Speaker:

  • Toula Bellios, Director, Division of Policy & External Partnership (DPEP),
    Center for Program Integrity at the Centers for Medicare & Medicaid Services 

Call Recording click to listen or download (0:55:38)
Link to Call Notes (forthcoming)

January 15, 2014

Holding the Industry Accountable: Covering Pharmaceutical Industry Marketing Practices

Featured Speaker:

  • Ed Silverman, Pharmalot, Past Editor

Call Recording click to listen or download (1:02:00)
Link to Call Notes 

November 6, 2013

Covering & Exposing Pharmaceutical Industry Relationships

with ProPublica “Dollars for Docs” reporters:

  • Charles Ornstein, Senior Reporter, ProPublica
  • Tracy Weber, Reporter, ProPublica

Call Recording click to listen or download (1:00:09)
Link to Call Notes 

August 28, 2013

How I Sold Low–T:
Guarding against Industry Influence

Featured Speaker:

  • Stephen Braun, Medical Writer
    Amherst, Massachusetts

Call Recording – click to listen or download (1:00:31)
Link to Call Notes

June 26, 2013

Rx Information: Non Biased and Evidenced-based or Industry Influenced?

Featured Speakers:

  • Michael Fischer, M.D., M.S.
    Director, National Resource Center for Academic Detailing (NARCAD)
  • Noah Nesin, M.D., FAAFP
    Chief Quality Officer, Penobscot Community Health Care

Call Recording – click to listen or download (1:02:43)
Link to Call Notes

May 1, 2013

Teaching Tools to Counter Pharma Marketing Tactics

Featured Speakers:

  • Adriane Fugh-Berman, MD

Director of PharmedOut and Associate Professor in the Department of Pharmacology and Physiology and in the Department of Family Medicine at Georgetown University Medical Center

  • Doris Peter, PhD

Associate Director, Health Ratings Center; Principle Investigator, Best Buy Drugs Project at Consumer Reports

Call Recording – click to listen or download (58:30)
Link to Call Notes

February 27, 2013

Let the Sun Shine In: Disclosing Industry Payments to Physicians Under the “Physician Payment Sunshine Act


Featured Speaker:

Wells Wilkinson, JD, Director of the Prescription Access Litigation (PAL) project and staff attorney with Community Catalyst

Call Recording – click to listen or download (54:41)
Link to Call Notes

December 19, 2012

Massachusetts Gift Ban Rules:
Rallying to Limit Industry Wining & Dining

Featured Speakers:

  • Alyssa R. Vangeli, JD, MPH, Health Care For All – Health Insurance and Delivery System Policy Analyst
  • Mary Carol Jennings, MD, National Physicians Alliance – Board of Directors American Medical Student Association – Past Jack Rutledge Legislative Director
  • David Tian, National Chair, AMSA PharmFree, MD/MPP Candidate, Harvard Medical and Kennedy Schools (Graduating in May 2013)

Call Recording – click to listen or download
Link to Call Notes

November 1, 2012

The Latest Settlement:
New Opportunities to Correct Misinformation

Featured Speaker:

  • Wells Wilkinson, JD, Director of the Prescription Access Litigation (PAL) project and staff attorney with Community Catalyst

Call Recording – click to listen or download (1:01:20)
Link to Call Notes

August 29, 2012

One Doctor’s Experience with Conflict of Interest and an Update on Physician Payment Sunshine Provisions of the ACA

Featured Speakers:

  • Daniel Carlat, MD, Director of the Pew Prescription ProjectDr. Carlat will describe his personal experience with COI as a well-meaning physician representing a drug company in educating prescribers about the benefits of a prescription drug and his current work in strengthening conflict-of-interest policies at medical schools and hospitals across the country. See Dr. Carlat’s 2007 New York Times Magazine article, Dr. Drug Rep and his recent editorial in the Philadelphia Inquirer, Disclosure Can Address Doctors’ Conflicts of Interest
  • Allan Coukell, Director of Medical Programs, Pew Health GroupAs Director of the Pew Health Group Medical Programs, Allan oversees the work of the Pew Prescription Project, the Medical Device Initiative, the Drug Safety Project, the Antibiotics and Innovation Project and other PHG activities related to medical products and services. He actively participated in the development of federal and state policy to foster transparency of physician-industry relationships and in the creation of programs to encourage evidence-based prescribing. Allan will discuss the status of the Physician Payment Sunshine provisions of the Patient Protection and Affordable Care Act.

Call Recording – click to listen or download (58:21)
Link to Call Notes

June 20, 2012

Recognizing the Potential for Conflicts of Interest and Initiating Change

Featured Speakers:

  • David Grande, MD, MPA, Assistant Professor of Medicine and a Senior Fellow at the Leonard Davis Institute of Health Economics at the University of PennsylvaniaDr. Grande is a general internist and practices at the academic general medicine practice in West Philadelphia and attends at the Hospital of the University of Pennsylvania. His research focuses on health policy for vulnerable populations and the influences of marketing in health care and on the medical profession. Dr. Grande will discuss his own experiences promoting policies to limit conflicts of interest as a faculty member and previously as a resident.
  • Reshma Ramachandran, American Medical Student Association, PharmFree FellowReshma is a rising fourth year medical student at Warren Alpert School of Medicine at Brown University. She will discuss her new role as AMSA’s PharmFree Fellow including promoting evidence-based and not marketing based medical education as well as other opportunities to become involved in the PharmFree campaign related to limiting conflicts of interest in both the classroom and on the wards.

Call Recording – click to listen or download (58:01)
Link to Call Notes



April 18, 2012

Dealing with Conflicts of Interest in Academic Medical Centers

Featured Speakers:

  • Guy Chisolm, PhD, Cleveland Clinic, Vice Chair, Lerner Research InstituteDirector, Innovation Management and Conflict of Interest ProgramCleveland Clinic was the first AMC in the country to disclose publicly their faculty’s industry ties
  • Stephen Smith, MD, MPH, Brown University, Professor Emeritus of Family MedicineFounding member of the National Physicians Alliance, currently serving as the physician consultant to Community Catalyst, which is working with medical schools and AMCs to develop strong COI policy through the Partnership to Advance Conflict-free Medical Education
  • Call Recording – click to listen or download (58:14)Link to Call Notes

February 22, 2012

New Partnership for the Advancement of Conflict-free Medical Education (PACME) and the AMSA PharmFree Scorecard

Featured Speakers:

  • Ann Woloson, Director of Education, National Physicians Alliance
  • Lee Shapely, Director, AMSA PharmFree ScorecardFourth Year Medical Student at Oregon Health & Science University
  • A Student’s Experience – Brigitte Frett, First Year Student at University of Miami School of Medicine

Call Recording – click to listen or download (52:36)

Link to Call Notes

For more information about these conference calls, please contact Becky Martin, NPA Director of Project Management,


NPA is a proud partner in the Partnership to Advance Conflict-free Medical Education (PACME). Our participation in these events is made possible by a grant from the state Attorney General Consumer and Prescriber Education Grant Program which is funded by the multi-state settlement of consumer fraud claims regarding the marketing of the prescription drug Neurontin.